Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Wednesday, December 12, 2018 · 470,866,844 Articles · 3+ Million Readers

The Overlap of 3D Bioprinting and 3D Cell Culturing in Cancer Research

3D Cell Culture 2018

3D Cell Culture 2018

SMi Reports: 3D Cell Culture 2018 to feature a line-up of scientific case studies on clinical developments

The implementation of CRISPR-based cell engineering is currently having a tremendous impact in research projects”
— Immunocore
LONDON, ENGLAND, UNITED KINGDOM, November 28, 2017 / -- SMi’s 3D Cell Culture conference will gather together a room full of CEOs, scientific pioneers and senior decision makers directly under one roof. Taking place in London on 21st and 22nd February 2018, the theme for the 2nd annual show is to strengthen commercial success through combining clinical breakthroughs with scientific research.

Highlights will include a look into the overlap of 3D bioprinting and 3D cell culturing in cancer research through a case study presented by Nicholas Leslie.

Nick is a cancer cell biologist and a Professor at Heriot Watt University in Edinburgh and has extensively studied the tumour suppressor, PTEN. At HWU, much of his lab’s research is in collaboration with engineers, applying biofabrication methods and other new technologies to cancer research.

His unique experience will provide attendees with insight into the reliance of 3D bioprinting on spheroid models and cell organisation. Drawing from different disease models, guidance will also be given on achieving correct architecture and on the placement of cells in printing for improved modelling.

3D Cell Culture 2018 will also feature further case studies on:

1. Electrospun Micro-Scaffold Based Biology – A 3D Biology Approach to Overcome Challenges for Well-Based Screening by Gary Allenby, Business Development Director & Chief Scientific Officer, Aurelia Bioscience.

2. Merging Crispr-Editing and Single Cell Sequencing Technologies to Uncover the Biology of Human Neurodevelopmental Diseases in 3D: Case Studies with Zika Virus and Tuberous Sclerosis by Max Salick, Postdoctoral Researcher, Novartis Institutes For Biomedical Research.

3. Next Generation Jellyfish Collagen – Applications for 3D Cell Culture by Andrew Spragg, CEO, Jellagen.

4. Fast Whole Well Imaging Using the Celigo Image Cytometer by Scott Cribbes, Director of New Technologies & Emerging Markets, Nexcelom.

Further information including a full speaker line-up and detailed agenda is available online at

3D Cell Culture 2018 is sponsored by Jellagen Pty Ltd and Nexcelom Bioscience. It will take place on 21st and 22nd February at the Holiday Inn Kensington Forum in Central London, UK.


Contact Information:

For media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email:
For all other enquires contact the team on Tel: +44 (0)20 7827 6000 or email

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

Teri Arri
SMi Group
email us here

Powered by EIN Presswire

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release